W48 Response Rate of Boceprevir-PegIFN-RBV in Treatment-Experienced HIV Coinfected Patients with HCV genotype 1: ANRS-HC27 BocepreVIH Study - Université de Rennes Accéder directement au contenu
Communication Dans Un Congrès Hepatology Année : 2013

W48 Response Rate of Boceprevir-PegIFN-RBV in Treatment-Experienced HIV Coinfected Patients with HCV genotype 1: ANRS-HC27 BocepreVIH Study

Fichier non déposé

Dates et versions

hal-00958556 , version 1 (12-03-2014)

Identifiants

  • HAL Id : hal-00958556 , version 1

Citer

Isabelle Poizot-Martin, Eric Bellissant, Lionel Piroth, Alain Renault, Marc Bourlière, et al.. W48 Response Rate of Boceprevir-PegIFN-RBV in Treatment-Experienced HIV Coinfected Patients with HCV genotype 1: ANRS-HC27 BocepreVIH Study. 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Nov 2013, Washington, United States. pp.746A-746A. ⟨hal-00958556⟩
93 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More